Please refer to our Privacy policy for important information on the use of cookies. By continuing to use this website, you agree to this.

Press Release

News and Media - Interserve

Interserve wins £8.5m contract to design new centre for Genomics Partnership Wales

by Interserve Press Office | May 26, 2020

Interserve Group Limited, the international support services, construction and equipment group, has been awarded the contract to design Genomics Partnership Wales’ new £8.5m research centre and offices by the Cardiff & Vale University Health Board.

Genomics Partnership Wales (GPW) – Partneriaeth Genomeg Cymru – has been formed to establish a united approach to genomics in Wales and represents a number of organisations across several disciplines to fast-track the development of pharmaceuticals as laid out in the Welsh Government’s Genomics Strategy.

Its work will be crucial in supporting the Government and other organisations seeking innovative medical solutions.

Key organisations include Welsh Government, the All Wales Medical Genetics Service, Wales Gene Park, Public Health Wales, Cardiff & Vale University Health Board and other higher education institutions in the principality.

Under the NHS Building for Wales Framework, Cardiff & Vale University Health Board has commissioned Interserve Construction to design the new genomics services facility in Cardiff which will involve the refurbishment of an existing two storey building, linked by circulation routes to neighbouring buildings

The redevelopment of the Maynard Centre, formerly occupied entirely by GE healthcare, at Forest Farm Industrial Estate, Cardiff on the site will see Interserve Construction create a new reception and waiting area; a treatment areas, genetics laboratories; office accommodation; seminar facilities; storage areas; freezer rooms and staff rest rooms.

The design work on the site has already commenced and construction work is scheduled to start in Spring 2021.

The building, which currently accommodates laboratories and office accommodation, will also include a containment level 2 laboratory space to ensure it is compliant with HBN 15 facilities for pathology services and the Advisory Committee on Dangerous Pathogens’ guidance on the management and operation of microbiological containment laboratories.

Carl Read, Divisional Director at Interserve Construction, said: “Given that the coronavirus is currently dominating the headlines in the UK, Interserve’s appointment to build this new, potentially life-saving, facility couldn’t be timelier.

“Genomics Partnership Wales and Cardiff & Vale University Health Board’s decision to appoint Interserve Construction to design the new £8.5m research centre further underscores our capabilities in delivering world-class medical facilities including the Christie’s Proton Beam Therapy Centre, Manchester, the University of Hull’s Allam Medical Building and the Prince Charles Hospital, Merthyr Tydfil.”


About Interserve Group Limited

Interserve Group Limited is one of the world’s foremost support services and construction companies. We offer design, construction, equipment, facilities management and frontline public services. We are headquartered in the UK and have consolidated revenues of £2.9bn and a workforce of circa 53,500 people worldwide.

Share this